Short answer
Prestige Consumer Healthcare Inc. (PBH) filed an 8-K current report with the SEC on July 15, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). $400.0M senior notes issued at 6.250% interest, maturing July 15, 2034.
Prestige Consumer Healthcare Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $400.0M senior notes issued at 6.250% interest, maturing July 15, 2034
- Annual interest expense of $25.0M, payable semiannually beginning January 15, 2027
- Senior unsecured debt guaranteed by Prestige Consumer Healthcare and certain domestic subsidiaries
- Proceeds increase leverage, while covenants restrict additional debt, dividends, buybacks, liens, and asset sales
- Change-of-control put at 101% of principal; issuer redemption begins July 15, 2029
Item 2.03 · Creation of a Direct Financial Obligation
- Indenture dated July 15, 2026 establishes the terms governing Prestige’s 2026 notes
- Prestige Brands, Inc. and affiliated guarantors are obligated under the note structure
- U.S. Bank Trust Company, National Association serves as trustee
- Note-specific terms are contained in the incorporated 2026 Note form and indenture exhibits
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prestige Consumer Healthcare Inc. 8-K filings
Get the next PBH 8-K as it lands
Follow PBH for push alerts, or ask the research agent what this filing means.